Need to upgrade the terminal performance of earlier-generation weapons systems that have lost their relevance, in order to rapidly give the armed forces back mass, and diplomacy leverage, through the provision of modernized equipment.<\/p>\n
This can be achieved by expanding the range of anti-tank ammunition available, backward-compatible with legacy 105 mm caliber weapon systems. The adoption of a separated chamber ammunition, based on the innovation described in the patent FR 22 04909, should deliver the terminal performance gains needed to bring Leopard 1, AMX 30 and first-generation Abrams tanks back to the forefront in the context of a high-intensity conflict. The implementation of a new ammunition is also an opportunity to modernize production resources by adopting global manufacturing processes in phase with the industrial fabric of developed countries, as demonstrated by the innovation protected by patent FR 24 11345, while guaranteeing that newly produced ammunition meets the MURAT \/ STANAG 4439 safety standard.<\/p>\n
Patents: FR 22 04909 and FR 24 11345
\nProtected countries : Europe + United States + Israel + South Korea<\/p>\n","protected":false},"excerpt":{"rendered":"
Sunt asperiores eos cumque officiis a quae placeat aut laborum.<\/p>\n","protected":false},"author":1,"featured_media":2683,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,28],"tags":[],"class_list":["post-491","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-armament","category-news"],"yoast_head":"\n